Search Results
Found 1 results
510(k) Data Aggregation
(832 days)
Disposable syringe for insulin administration, for the patient with diabetes.
Insulin syringe with integrated extra thin stainless-steel needle and dead space less than 0.005 ml, made of medical grade plastic, sterile, disposable, pyrogen free and non-toxic. Sterilized by ethylene oxide. The product is composed of the following parts: Cylinder or barrel, Piston, Plunger, Needle, Needle cover or protector.
This document describes the acceptance criteria and study results for the "Insulin syringe with integrated needle DL®" (proposed device), demonstrating its substantial equivalence to a predicate device (Disposable Insulin Syringe, K162180).
1. Table of Acceptance Criteria and Reported Device Performance
The acceptance criteria are primarily derived from international standards (ISO series) and national standards (MGA, NOM). The "Specifications" column represents the acceptance criteria, and the "Insulin syringe with integrated needle DLPJECT®" column represents the reported device performance.
| # | Test | Acceptance Criteria (Specifications) | Reported Device Performance ("Insulin syringe with integrated needle DLPJECT®") |
|---|---|---|---|
| 1 | Product designation | Insulin syringe with integrated needle. Syringe type 7. Capacity: 0.3 mL and 1 mL. Sterile and disposable. | Insulin syringe with integrated needle. Syringe type 7. Capacity: 0.3 mL and 1 mL. Sterile and disposable. |
| 2 | Product description | Medical use article, disposable, sterile, pyrogen-free, non-reactive tissue materials. Must be sterile, non-toxic, pyrogen-free and non-reactive tissue. | Compliant (detailed description provided) |
| Cylinder or barrel (clarity, lubrication, length, scale) | Enough clarity to see dosage and identify bubbles. Interior lubricated with medical grade silicone (no drops). Minimum length 79 mm. Insulin unit scale (min 57 mm). Graduation lines on longitudinal axis. | Compliant (detailed description provided) | |
| Graduation lines (length, numbering, appearance) | Longer lines for zero and every five lines (approx half length of zero). Zero starts at perimeter. Clear numbering (10, 20...100 U.). "U.I." and "U-100" at end. "mL" or "ml" for total capacity. "Not reusing" symbol. Numbers >= 3mm. Lines 0.2-0.4mm thick. Clear contrast. | Compliant (detailed description provided) | |
| Plunger | Operated inside cylinder/barrel. Protrusion at distal end prevents slipping. Piston assembled at opposite end. Plunger + piston length 88 x 2 mm. | Compliant (detailed description provided) | |
| Needle | Puncture device attached to syringe for liquid introduction. May have medical grade silicone coating. | Compliant (detailed description provided) | |
| Needle cover or protector | Medical grade plastic, perfectly covers needle, protects edge, avoids accidental punctures. | Compliant (detailed description provided) | |
| 3 | Finish | Free of defects (burrs, bubbles, perforations, fractures, roughness, deformations, sharp parts, non-uniform thickness). Needle assembly firm and not separated by normal use. | Compliant (detailed description provided) |
| 4 | Dimensions | Volume (mL/cc): 0.3, 0.5, 1.0Scale division (ml): 5 U.I.Scale subdivision (ml): 1 U.I. (0.3/0.5ml), 2 U.I. (1.0ml)Min length of scale (mm): 41.0 (0.3ml), 43.0 (0.5ml), 57.0 (1.0ml)Max silicone mass (mg): Lubricant will not form fluid droplets on inner surface. | Compliant (values match specification)Compliant (values match specification)Compliant (values match specification)Compliant (values match specification)Compliant (matches specification) |
| Scale tolerance (when ref line > 50% nominal capacity) | ± 5% (0.3ml), ± 4% (0.5ml), ± 4% (1.0ml) | Compliant (values match specification) | |
| 5 | Scale numbering | 0.5 units (0.3ml), 1.0 units (0.5ml), 2.0 units (1.0ml) | Compliant (values match specification) |
| 6 | Scale position | Ends of similarly long graduation lines align vertically with barrel axis and each other (tolerance +0.5mm) when held vertically. | Compliant (matches specification) |
| 7 | Characteristics of the cylinder or barrel | Eyebrow/flange for finger support. Enough clarity. Lubricated with medical grade silicone (no drops). Useful capacity no less than 10% more than nominal capacity or 3mm plunger travel beyond scale mark (whichever is less). | Compliant (detailed description provided) |
| 8 | Flange | Syringe does not rotate more than 180° when placed on a flat surface with scale upwards at 10° from horizontal. | Compliant (matches specification) |
| 9 | Plunger and piston features | Plunger can be pushed by thumb when barrel is held with one hand. Plunger head has grooves to prevent slipping. | Compliant (matches specification) |
| 10 | Reference line | Defined, visible edge at piston end for capacity reference. In contact with inner surface of barrel. | Compliant (matches specification) |
| 11 | Dead space | Volume in barrel/cylinder and pivot when piston fully inserted: max 0.005 mL. | Compliant (matches specification) |
| 12 | Hypodermic Needle (Dimensions) | Gauge (G): 30, 31, 32Nominal external diameter (mm): 0.298-0.320 (30G), 0.254-0.266 (31G), 0.229-0.241 (32G)Minimum nominal inner diameter (mm): 0.133 (30G), 0.114 (31G), 0.089 (32G)Useful length: Needle length tolerance within ± 1.25 mm.Primary angle: 9° to 11°Color code: Orange for U-100 | Compliant (values match specification)Compliant (values match specification)Compliant (values match specification)Compliant (matches specification)Compliant (matches specification)Compliant (matches specification) |
| 13 | Cannula adhesion (N) | Minimum joint resistance of needle tube with nominal external diameter < 0.33 should be 11 N. | Complies (matches specification) |
| 14 | Hermeticity | None of the syringes should leak. | Complies (matches specification) |
| 15 | Systemic injection | MGA-DM 3083. Passes the Test. | Passes the Test. |
| 16 | Intracutaneous reactivity | MGA-DM 3071. Passes the Test. | Passes the Test. |
| 17 | Pyrogens | MGA 0711 or MGA 0316 (Bacterial Endotoxins). Satisfies the test method. | Satisfies the test method. |
| 18 | Sterility | MGA 0381. Passes the Test. | Passes the Test. |
| 19 | Ethylene oxide residues | Complies with ISO 10993-7:2008, 4 mg maximum/24h. | Complies with ISO 10993-7:2008, 4 mg maximum/24h. |
| 20 | Acidity or alkalinity | MGA-DM 0001, Method II, Test compliance. | Test compliance. |
| 21 | Removable metal limit | Sample extract in total < 5 mg/L of lead, tin, zinc, iron. Cadmium content < 0.1 mg/L. | Complies (matches specification) |
| 22 | Product marking | Clear, legible, permanent characters: name, company name/symbol, nominal capacity (cm3 or ml), single graduated scale. | Complies (matches specification) |
| 23 | Label and counter-label NOM-137-SSA1-2008 | Complies with NOM-137-SSA1-2008, Medical Device Labeling. | Complies with NOM-137-SSA1-2008. |
| 24 | Labeling of the primary Packaging / RIS health supplies regulation | Complies with the provisions of the Regulation of Inputs for Health. Second section. Labeling and packaging. | Complies with the provisions. |
| Biocompatibility Tests | |||
| Cytotoxicity (elution) | Reactivity grade: 0 - 2 | Reactivity grade: 0 (None, Not cytotoxic) | |
| Cytotoxicity (agar diffusion) | Reactivity grade: 0 - 2 | Reactivity grade: 0 (None, Not cytotoxic) | |
| Irritability | 0 to 0.4: Not measurable | 0.0: Not measurable | |
| Sensitization | Grade 0: No visible change; Grade 1: Slight or irregular erythema; Grade 2: Moderate and confluent erythema; Grade 3: Intense erythema or swelling | Grade 0: No visible change | |
| Systemic Toxicity | No significantly greater biological reaction than blank in treated animals. | No significantly greater biological reaction than blank in treated animals. | |
| Pyrogens | For information only (sum of temperature increments). | Sum of temperature increments 0.26 °C; considered apyrogenic. | |
| Acute toxicity | Saline solution extract of medical device must not show adverse clinical effects. | Saline solution extract did not show adverse clinical effects. | |
| Subacute toxicity | Saline solution extract of medical device must not show adverse clinical effects. | Saline solution extract did not show adverse clinical effects. | |
| Subchronic toxicity | Saline solution extract of medical device must not show adverse clinical effects. | Saline solution extract did not show adverse clinical effects. | |
| Sterility | |||
| Sterilization method | Ethylene oxide (validated per ISO 11135-1.2015). | Ethylene oxide. Validated per ISO 11135-1.2015. | |
| Pyrogens (ISO 10993-12) | Compliant with ISO 10993-12. | Compliant with ISO 10993-12. | |
| Sterility Assurance Level (SAL) | 10-6 | Minimum SAL of 10-6. | |
| Microbial Ingress (Sterile barrier) | Passes analytical test procedures. | Passes analytical test procedures. | |
| Syringe air bubble leak (Sterile barrier) | Passes analytical test procedures. | Passes analytical test procedures. | |
| Packaging Integrity | ASTM D4109-22: acceptable for protection and sterility. | Acceptable per ASTM D4109-22. | |
| Shelf-life | Supported by real-time stability testing. | Real time stability testing supports shelf-life of years. |
2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)
The document extensively references international ISO standards (e.g., ISO 9626:2016, ISO 7864-1:2016, ISO 8537:2016, ISO 10993 series) and national standards (MGA, NOM-137-SSA1-2008, ASTM D4109-22). These standards typically specify the number of samples required for each test. For instance:
- ISO 10993 (Biocompatibility): Tests like cytotoxicity, irritation, sensitization, acute, subacute, and subchronic toxicity, and pyrogenicity often involve in-vitro (cell cultures) or in-vivo (animal models like Wistar rats) testing with specific animal group sizes outlined in the respective ISO parts. For example, Pyrogens in Table 3 mentions "The sum of the temperature increments of the test animals is 0.26 °C so the sample is considered apyrogenic," implying in-vivo testing.
- Physical/Performance Tests (e.g., Dimensions, Cannula adhesion, Hermeticity): These are typically performed on a statistically significant number of production samples according to the specific test methods outlined in the cited ISO standards. While exact numbers are not explicitly stated in this summary, the compliance with these standards implies that the required sample sizes were met.
The data provenance is not explicitly stated as "country of origin." However, the tests are conducted in accordance with international (ISO) and potentially national (MGA, NOM from Mexico, given the submitter's address) standards, suggesting these tests were performed in certified laboratories adhering to these guidelines. The studies appear to be prospective as they are testing the newly developed "Insulin syringe with integrated needle DL®" against established criteria.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts
This type of medical device (insulin syringe) does not typically involve human expert "ground truth" establishment in the same way an AI diagnostic algorithm might. The "ground truth" for the performance and biocompatibility tests is based on objective measurements and established scientific protocols as defined by the international standards (ISO) and regulatory guidelines (MGA, NOM, ASTM). The "experts" involved would be the certified laboratory technicians and scientists performing these tests and interpreting the results against the defined specifications. Their qualifications would be in analytical chemistry, microbiology, toxicology, materials science, and medical device testing, following Good Laboratory Practice (GLP) and Good Manufacturing Practice (GMP) principles. The number of such professionals is generally defined by the laboratory's quality system and standard operating procedures for each test.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
Adjudication methods like "2+1" or "3+1" are typically used for establishing ground truth in subjective assessments for diagnostic devices (e.g., radiologists reviewing images). For this type of device, which relies heavily on objective physical, chemical, and biological testing, traditional adjudication methods are not applicable. The "adjudication" is inherent in the test methodology itself:
- Compliance with numerical specifications: If a measurement falls within the specified range, it passes.
- Qualitative observations: For tests like "Finish" (absence of defects) or "Cytotoxicity" (reactivity grade), trained personnel make observations and record results based on predefined criteria in the standard. If a result is deemed "Non-cytotoxic" or "Passes the Test" according to the standard's interpretation guidelines, it meets the criterion.
The reporting of results as "Complies," "Passes the Test," or specific measurement within tolerance indicates that the results were directly compared to the acceptance criteria without a separate adjudication panel.
5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
No, an MRMC comparative effectiveness study was not done. This type of study is relevant for AI-powered diagnostic tools where human readers (e.g., radiologists) interpret cases with and without AI assistance. The "Insulin syringe with integrated needle DL®" is a physical medical device, not a diagnostic imaging or AI software product, so such a study would not apply.
6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done
No, a standalone (algorithm-only) performance study was not done. This concept is also specific to AI/software as a medical device (SaMD) where an algorithm makes a determination independently. The device here is a physical syringe. Its "standalone" performance refers to its intrinsic physical and biological properties as tested against the standards.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)
The ground truth for this device's evaluation is primarily established through:
- International Standards and Regulatory Specifications: The core ground truth is defined by the detailed requirements and test methods of standards like ISO 9626, ISO 7864, ISO 8537, ISO 10993 series, MGA, NOM, and ASTM. These standards define acceptable material properties, dimensions, performance characteristics, and biological compatibility limits.
- Objective Measurement and Analytical Testing: Laboratory tests provide objective data (e.g., dimensional measurements, force required for cannula adhesion, chemical residue levels, cell reactivity grades, animal physiological responses) which are quantitatively or qualitatively compared to the predefined acceptance criteria from the standards.
- Biological Endpoints: For biocompatibility, endpoints like cell viability (cytotoxicity), skin reactions (irritation/sensitization), and animal physiological responses (pyrogenicity, acute/subchronic toxicity) serve as the ground truth indicators as interpreted against the ISO 10993 series.
8. The sample size for the training set
This device does not involve machine learning algorithms, thus there is no "training set" in the context of AI. The "training" in the manufacturing process refers to process validation and quality control, ensuring that the manufacturing process consistently produces devices meeting specifications. The exact numbers of units produced and tested during process validation are not provided, but they would be governed by internal quality systems and relevant manufacturing standards.
9. How the ground truth for the training set was established
As there is no AI training set for this physical device, this question is not applicable. The "ground truth" for the device's design and manufacturing process would refer to the adherence to verified design specifications, material inputs, and validated manufacturing procedures, all established through engineering principles, regulatory requirements, and quality management systems.
Ask a specific question about this device
Page 1 of 1